Prudential Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.36M | Sell |
32,465
-5,369
| -14% | -$956K | 0.01% | 828 |
|
|
2026
Q1 | $6.53M | Sell |
37,834
-152
| -0.4% | -$28.2K | 0.01% | 807 |
|
|
2025
Q4 | $7.58M | Sell |
37,986
-10,119
| -21% | -$1.84M | 0.01% | 734 |
|
|
2025
Q3 | $7.53M | Buy |
48,105
+9,701
| +25% | +$1.54M | 0.01% | 739 |
|
|
2025
Q2 | $5.83M | Buy |
38,404
+10,912
| +40% | +$1.46M | 0.01% | 845 |
|
|
2025
Q1 | $4.14M | Sell |
27,492
-804
| -3% | -$135K | 0.01% | 933 |
|
|
2024
Q4 | $5.28M | Sell |
28,296
-4,554
| -14% | -$877K | 0.01% | 854 |
|
|
2024
Q3 | $6.47M | Sell |
32,850
-209
| -0.6% | -$43.4K | 0.01% | 869 |
|
|
2024
Q2 | $6.83M | Sell |
33,059
-4,166
| -11% | -$944K | 0.01% | 799 |
|
|
2024
Q1 | $10.1M | Sell |
37,225
-1,922
| -5% | -$459K | 0.01% | 683 |
|
|
2023
Q4 | $8.89M | Sell |
39,147
-7,000
| -15% | -$1.38M | 0.01% | 699 |
|
|
2023
Q3 | $9.04M | Buy |
46,147
+92
| +0.2% | +$18.9K | 0.01% | 666 |
|
|
2023
Q2 | $9.68M | Buy |
46,055
+701
| +2% | +$139K | 0.01% | 666 |
|
|
2023
Q1 | $9.65M | Sell |
45,354
-503
| -1% | -$114K | 0.02% | 651 |
|
|
2022
Q4 | $9.99M | Sell |
45,857
-6,915
| -13% | -$1.51M | 0.02% | 628 |
|
|
2022
Q3 | $10.1M | Sell |
52,772
-7,520
| -12% | -$1.62M | 0.02% | 639 |
|
|
2022
Q2 | $13.1M | Buy |
60,292
+8,369
| +16% | +$2.04M | 0.02% | 578 |
|
|
2022
Q1 | $14.7M | Buy |
51,923
+1,468
| +3% | +$453K | 0.02% | 599 |
|
|
2021
Q4 | $19.1M | Sell |
50,455
-3,420
| -6% | -$1.33M | 0.02% | 522 |
|
|
2021
Q3 | $23.3M | Sell |
53,875
-16,397
| -23% | -$6.81M | 0.03% | 438 |
|
|
2021
Q2 | $26M | Buy |
70,272
+708
| +1% | +$236K | 0.04% | 415 |
|
|
2021
Q1 | $20.2M | Sell |
69,564
-56,505
| -45% | -$15.7M | 0.03% | 490 |
|
|
2020
Q4 | $31.5M | Sell |
126,069
-74
| -0.1% | -$17.6K | 0.05% | 309 |
|
|
2020
Q3 | $28.6M | Buy |
126,143
+2,504
| +2% | +$520K | 0.05% | 313 |
|
|
2020
Q2 | $21.6M | Sell |
123,639
-133,460
| -52% | -$21.3M | 0.04% | 397 |
|
|
2020
Q1 | $32.4M | Sell |
257,099
-86,064
| -25% | -$12.9M | 0.07% | 265 |
|
|
2019
Q4 | $52.4M | Sell |
343,163
-8,201
| -2% | -$1.14M | 0.08% | 256 |
|
|
2019
Q3 | $46.5M | Sell |
351,364
-152,543
| -30% | -$20.5M | 0.07% | 286 |
|
|
2019
Q2 | $71.5M | Sell |
503,907
-20,238
| -4% | -$2.74M | 0.11% | 184 |
|
|
2019
Q1 | $76.1M | Buy |
524,145
+217,466
| +71% | +$28.6M | 0.13% | 161 |
|
|
2018
Q4 | $34.7M | Sell |
306,679
-60,068
| -16% | -$7.52M | 0.06% | 337 |
|
|
2018
Q3 | $49.3M | Sell |
366,747
-17,230
| -4% | -$2.13M | 0.07% | 285 |
|
|
2018
Q2 | $43.1M | Buy |
383,977
+70,723
| +23% | +$7.65M | 0.06% | 333 |
|
|
2018
Q1 | $33.4M | Sell |
313,254
-122,160
| -28% | -$13.2M | 0.05% | 422 |
|
|
2017
Q4 | $47.7M | Buy |
435,414
+1,744
| +0.4% | +$190K | 0.06% | 338 |
|
|
2017
Q3 | $46.8M | Buy |
433,670
+7,810
| +2% | +$802K | 0.07% | 331 |
|
|
2017
Q2 | $43.1M | Buy |
425,860
+68,058
| +19% | +$6.26M | 0.06% | 347 |
|
|
2017
Q1 | $32.2M | Sell |
357,802
-2,842
| -0.8% | -$241K | 0.05% | 427 |
|
|
2016
Q4 | $27.5M | Buy |
360,644
+30,010
| +9% | +$2.28M | 0.04% | 461 |
|
|
2016
Q3 | $27.6M | Sell |
330,634
-20,295
| -6% | -$1.7M | 0.05% | 447 |
|
|
2016
Q2 | $28.9M | Sell |
350,929
-4,370
| -1% | -$360K | 0.05% | 422 |
|
|
2016
Q1 | $27M | Sell |
355,299
-28,950
| -8% | -$2.14M | 0.05% | 405 |
|
|
2015
Q4 | $30.9M | Buy |
384,249
+103,890
| +37% | +$7.49M | 0.06% | 362 |
|
|
2015
Q3 | $17.8M | Buy |
280,359
+17,540
| +7% | +$1.26M | 0.04% | 519 |
|
|
2015
Q2 | $18.5M | Sell |
262,819
-14,490
| -5% | -$1.07M | 0.03% | 570 |
|
|
2015
Q1 | $22M | Sell |
277,309
-3,240
| -1% | -$239K | 0.04% | 516 |
|
|
2014
Q4 | $17.9M | Sell |
280,549
-20,500
| -7% | -$1.29M | 0.03% | 526 |
|
|
2014
Q3 | $18M | Sell |
301,049
-86,414
| -22% | -$4.94M | 0.03% | 512 |
|
|
2014
Q2 | $20.7M | Buy |
387,463
+163,214
| +73% | +$8.96M | 0.04% | 488 |
|
|
2014
Q1 | $13.5M | Sell |
224,249
-13,700
| -6% | -$799K | 0.03% | 612 |
|
|
2013
Q4 | $12.6M | Buy |
237,949
+54,950
| +30% | +$2.76M | 0.03% | 612 |
|
|
2013
Q3 | $8.47M | Buy |
182,999
+24,337
| +15% | +$1.12M | 0.02% | 724 |
|
|
2013
Q2 | $6.51M | Buy |
+158,662
| New | +$6.8M | 0.01% | 796 |
|
Other funds holding CRL
AI
Prudential Financial's CRL Position: Q2 2026 in Review
Prudential Financial reduced its Charles River Laboratories (CRL) stake by 14% in Q2 2026, selling an estimated $956K and leaving 32,465 shares worth $7.36M. The position accounts for 0.01% of the portfolio, ranked #828.
Prudential Financial first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $76.1M in Q1 2019. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Prudential Financial held 32,465 shares of Charles River Laboratories worth $7.36M as of Q2 2026.
- Prudential Financial sold 5,369 Charles River Laboratories shares in Q2 2026, an estimated $956K.
- Charles River Laboratories made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #828 holding.
- Prudential Financial first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Prudential Financial's Charles River Laboratories position peaked at $76.1M in Q1 2019.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.